TMEM88 and breast carcinoma: The above results show that the expression level of TMEM88 has certain differences in different types of breast cancer, and the cytoplasmic level and nuclear expression of TMEM88 have obvious tissue distribution specificity, which may facilitate TMEM88 becoming a promising therapeutic target for the treatment of breast cancer; however, the specific mechanism and intervention potential need further research to clarify.